|
1
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lordick F and Hoffmeister A: Treatment of
gastric cancer. Internist (Berl). 55:15–16, 18-22. 2014.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frejlich E, Rudno-Rudzińska J, Janiszewski
K, Salomon L, Kotulski K, Pelzer O, Grzebieniak Z, Tarnawa R and
Kielan W: Caspases and their role in gastric cancer. Adv Clin Exp
Med. 22:593–602. 2013.PubMed/NCBI
|
|
5
|
Crawford ED and Wells JA: Caspase
substrates and cellular remodeling. Annu Rev Biochem. 80:1055–1087.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chowdhury I, Tharakan B and Bhat GK:
Caspases-an update. Comp Biochem Physiol B Biochem Mol Biol.
151:10–27. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mace PD, Riedl SJ and Salvesen GS: Caspase
enzymology and activation mechanisms. Methods Enzymol. 544:161–178.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lánczky A, Nagy Á, Bottai G, Munkácsy G,
Szabó A, Santarpia L and Győrffy B: miRpower: A web-tool to
validate survival-associated miRNAs utilizing expression data from
2178 breast cancer patients. Breast Cancer Res Treat. 160:439–446.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dalma-Weiszhausz DD, Warrington J,
Tanimoto EY and Miyada CG: The affymetrix GeneChip platform: An
overview. Methods Enzymol. 410:3–28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du H, Song GX, Fang MZ, Shu YQ, Zhao X and
Zhu LJ: A meta-analysis of caspase-8 −652 6N del polymorphism and
digestive tract cancer risk. J Biomed Res. 33:173–180.
2019.PubMed/NCBI
|
|
14
|
Kanehara I, Nakata B and Hirakawa K:
Caspase-8 is scarcely silenced and its activity is well correlated
with the anticancer effect of tumor necrosis factor-related
apoptosis-inducing ligand in gastric cancer cells. Oncol Rep.
14:1249–1253. 2005.PubMed/NCBI
|
|
15
|
Boege Y, Malehmir M, Healy ME, Bettermann
K, Lorentzen A, Vucur M, Ahuja AK, Böhm F, Mertens JC, Shimizu Y,
et al: A dual role of caspase-8 in triggering and sensing
proliferation-associated DNA damage, a key determinant of liver
cancer development. Cancer cell. 32:342.e10–359.e10. 2017.
View Article : Google Scholar
|
|
16
|
Gu Q, Wang JD, Xia HH, Lin MC, He H, Zou
B, Tu SP, Yang Y, Liu XG, Lam SK, et al: Activation of the
caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in
gastric cancer. Carcinogenesis. 26:541–546. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Wu K and Yu WP: The expression and
activity of caspase-8 in the process of vitamin E succinate-induced
apoptosis in human gastric carcinoma SGC-7901 cells. Zhonghua Yu
Fang Yi Xue Za Zhi. 37:112–114. 2003.(In Chinese). PubMed/NCBI
|
|
18
|
Mondal A and Bennett LL: Resveratrol
enhances the efficacy of sorafenib mediated apoptosis in human
breast cancer MCF7 cells through ROS, cell cycle inhibition,
caspase 3 and PARP cleavage. Biomed Pharmacother. 84:1906–1914.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mantena SK, Sharma SD and Katiyar SK:
Berberine inhibits growth, induces G1 arrest and apoptosis in human
epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin
cascade, disruption of mitochondrial membrane potential and
cleavage of caspase 3 and PARP. Carcinogenesis. 27:2018–2027. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yinjun L, Jie J, Weilai X and Xiangming T:
Homoharringtonine mediates myeloid cell apoptosis via upregulation
of pro-apoptotic bax and inducing caspase-3-mediated cleavage of
poly(ADP-ribose) polymerase (PARP). Am J Hematol. 76:199–204. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tyagi A, Agarwal C, Harrison G, Glode LM
and Agarwal R: Silibinin causes cell cycle arrest and apoptosis in
human bladder transitional cell carcinoma cells by regulating
CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Carcinogenesis. 25:1711–1720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vormoor B, Schlosser YT, Blair H, Sharma
A, Wilkinson S, Newell DR and Curtin N: Sensitizing Ewing sarcoma
to chemo- and radiotherapy by inhibition of the DNA-repair enzymes
DNA protein kinase (DNA-PK) and poly-ADP-ribose polymerase (PARP)
1/2. Oncotarget. 8:113418–113430. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alikarami F, Safa M, Faranoush M, Hayat P
and Kazemi A: Inhibition of DNA-PK enhances chemosensitivity of
B-cell precursor acute lymphoblastic leukemia cells to doxorubicin.
Biomed Pharmacother. 94:1077–1093. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho HJ, Kim IK, Park SM, Baek KE, Nam IK,
Park SH, Ryu KJ, Choi J, Ryu J, Hong SC, et al: VEGF-C mediates
RhoGDI2-induced gastric cancer cell metastasis and cisplatin
resistance. Int J Cancer. 135:1553–1563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng Z, He XY, Li JF, Yu BQ, Chen XH, Ji
J, Zhang JN, Gu QL, Zhu ZG and Liu BY: RhoGDI2 confers resistance
to 5-fluorouracil in human gastric cancer cells. Oncol Lett.
5:255–260. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Essmann F, Wieder T, Otto A, Müller EC,
Dörken B and Daniel PT: GDP dissociation inhibitor D4-GDI (Rho-GDI
2), but not the homologous rho-GDI 1, is cleaved by caspase-3
during drug-induced apoptosis. Biochem J 346 Pt. 3:777–783. 2000.
View Article : Google Scholar
|
|
27
|
Fiorillo M, Peiris-Pagès M,
Sanchez-Alvarez R, Bartella L, Di Donna L, Dolce V, Sindona G,
Sotgia F, Cappello AR and Lisanti MP: Bergamot natural products
eradicate cancer stem cells (CSCs) by targeting mevalonate,
Rho-GDI-signalling and mitochondrial metabolism. Biochim Biophys
Acta Bioenerg. 1859:984–996. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu Z, Wu L, Weng D, Xu D, Geng J and Zhao
F: Reduced expression of lamin A/C correlates with poor
histological differentiation and prognosis in primary gastric
carcinoma. J Exp Clin Cancer Res. 28:82009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gibot L, Follet J, Metges JP, Auvray P,
Simon B, Corcos L and Le Jossic-Corcos C: Human caspase 7 is
positively controlled by SREBP-1 and SREBP-2. Biochem J.
420:473–483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamy L, Ngo VN, Emre NC, Shaffer AL III,
Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O and
Staudt LM: Control of autophagic cell death by caspase-10 in
multiple myeloma. Cancer Cell. 23:435–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hitzler I, Sayi A, Kohler E, Engler DB,
Koch KN, Hardt WD and Müller A: Caspase-1 has both proinflammatory
and regulatory properties in Helicobacter infections, which are
differentially mediated by its substrates IL-1β and IL-18. J
Immunol. 188:3594–3602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yaguchi T, Saito M, Yasuda Y and Nishizaki
T: Caspase-4 activation in association with decreased adenosine
deaminase activity may be a factor for gastric ulcer. Digestion.
81:62–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Namiot Z, Kemona A, Stasiewicz J,
Marcinkiewicz M, Namiot A and Gorski J: Adenosine deaminase
activity in gastric cancer. Cancer Lett. 82:95–98. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Terlizzi M, Colarusso C, De Rosa I, De
Rosa N, Somma P, Curcio C, Sanduzzi A, Micheli P, Molino A,
Saccomanno A, et al: Circulating and tumor-associated caspase-4: A
novel diagnostic and prognostic biomarker for non-small cell lung
cancer. Oncotarget. 9:19356–19367. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raposo TP, Beirão BC, Pang LY, Queiroga FL
and Argyle DJ: Inflammation and cancer: Till death tears them
apart. Vet J. 205:161–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Viganò E, Diamond CE, Spreafico R,
Balachander A, Sobota RM and Mortellaro A: Human caspase-4 and
caspase-5 regulate the one-step non-canonical inflammasome
activation in monocytes. Nat Commun. 6:87612015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Williams TM, Leeth RA, Rothschild DE,
McDaniel DK, Coutermarsh-Ott SL, Simmons AE, Kable KH, Heid B and
Allen IC: Caspase-11 attenuates gastrointestinal inflammation and
experimental colitis pathogenesis. Am J Physiol Gastrointest Liver
Physiol. 308:G139–G150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rao RV, Ellerby HM and Bredesen DE:
Coupling endoplasmic reticulum stress to the cell death program.
Cell Death Differ. 11:372–380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nakagawa T and Yuan J: Cross-talk between
two cysteine protease families. Activation of caspase-12 by calpain
in apoptosis. J Cell Biol. 150:887–894. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saleh M, Vaillancourt JP, Graham RK, Huyck
M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT,
Hotchkiss RS, et al: Differential modulation of endotoxin
responsiveness by human caspase-12 polymorphisms. Nature.
429:75–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Van de Craen M, Van Loo G, Pype S, Van
Criekinge W, Van den brande I, Molemans F, Fiers W, Declercq W and
Vandenabeele P: Identification of a new caspase homologue:
Caspase-14. Cell Death Differ. 5:838–846. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Koenig U, Sommergruber W and Lippens S:
Aberrant expression of caspase-14 in epithelial tumors. Biochem
Biophys Res Commun. 335:309–313. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Krajewska M, Kim H, Shin E, Kennedy S,
Duffy MJ, Wong YF, Marr D, Mikolajczyk J, Shabaik A,
Meinhold-Heerlein I, et al: Tumor-associated alterations in
caspase-14 expression in epithelial malignancies. Clin Cancer Res.
11:5462–5471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fang HY, Chen CY, Hung MF, Hsiao YT,
Chiang TC, Lin TY, Chang HW, Chow KC and Ko WJ: Caspase-14 is an
anti-apoptotic protein targeting apoptosis-inducing factor in lung
adenocarcinomas. Oncol Rep. 26:359–369. 2011.PubMed/NCBI
|
|
45
|
Ahmad M, Srinivasula SM, Wang L, Talanian
RV, Litwack G, Fernandes-Alnemri T and Alnemri ES: CRADD, a novel
human apoptotic adaptor molecule for caspase-2, and FasL/tumor
necrosis factor receptor-interacting protein RIP. Cancer Res.
57:615–619. 1997.PubMed/NCBI
|
|
46
|
Shen Q, Tang W, Sun J, Feng L, Jin H and
Wang X: Regulation of CRADD-caspase 2 cascade by histone
deacetylase 1 in gastric cancer. Am J Transl Res. 6:538–547.
2014.PubMed/NCBI
|
|
47
|
Taghiyev AF, Guseva NV, Glover RA, Rokhlin
OW and Cohen MB: TSA-induced cell death in prostate cancer cell
lines is caspase-2 dependent and involves the PIDDosome. Cancer
Biol Ther. 5:1199–1205. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yoo NJ, Lee JW, Kim YJ, Soung YH, Kim SY,
Nam SW, Park WS, Lee JY and Lee SH: Loss of caspase-2, −6 and −7
expression in gastric cancers. APMIS. 112:330–335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mandruzzato S, Brasseur F, Andry G, Boon T
and van der Bruggen P: A CASP-8 mutation recognized by cytolytic T
lymphocytes on a human head and neck carcinoma. J Exp Med.
186:785–793. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nicholson DW: Caspase structure,
proteolytic substrates, and function during apoptotic cell death.
Cell Death Differ. 6:1028–1042. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Logette E, Le Jossic-Corcos C, Masson D,
Solier S, Sequeira-Legrand A, Dugail I, Lemaire-Ewing S, Desoche L,
Solary E and Corcos L: Caspase-2, a novel lipid sensor under the
control of sterol regulatory element binding protein 2. Mol Cell
Biol. 25:9621–9631. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Acehan D, Jiang X, Morgan DG, Heuser JE,
Wang X and Akey CW: Three-dimensional structure of the apoptosome:
Implications for assembly, procaspase-9 binding, and activation.
Mol Cell. 9:423–432. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria: A
primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yoo NJ and Lee SH, Jeong EG and Lee SH:
Expression of phosphorylated caspase-9 in gastric carcinomas.
APMIS. 115:354–359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang H, Li H, Chen F, Luo J, Gu J, Wang H,
Wu H and Xu Y: Baicalin extracted from Huangqin (Radix Scutellariae
Baicalensis) induces apoptosis in gastric cancer cells by
regulating B cell lymphoma (Bcl-2)/Bcl-2-associated X protein and
activating caspase-3 and caspase-9. J Tradit Chin Med. 37:229–5.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chang-Qing F, Yi L, De-Guang W, Qing-Bin
S, Xiang-Min H, Na T and Jian-Hua L: Immune clearance gastric
carcinoma cells in ascites by activating caspase-9-induced
apoptosis. APMIS. 119:173–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen YC, Fang WL, Wang RF, Liu CA, Yang
MH, Lo SS, Wu CW, Li AF, Shyr YM and Huang KH: Clinicopathological
variation of lauren classification in gastric cancer. Pathol Oncol
Res. 22:197–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ma J, Shen H, Kapesa L and Zeng S: Lauren
classification and individualized chemotherapy in gastric cancer.
Oncol Lett. 11:2959–2964. 2016. View Article : Google Scholar : PubMed/NCBI
|
